In 2009 and 2013 investigators published studies that demonstrated improved outcomes in patients with IHCA who received vasopressin and steroids in addition to epinephrine. However, both US and European cardiac arrest guidelines have not endorsed these medications due to lack of additional evidence. In this podcast we discuss the recently published VAM-IHCA trial, which evaluated vasopressin and steroids for patients with IHCA. Should we now be administering this combination of medications along with epinephrine for IHCA?
You can get CME credit for this episode hereClick here for CME Account Creation Instructions
Acute aortic syndromes such as aortic dissection are incredibly stressful and challenging to manage. In this episode, we tackle the difficult management pearls and...
In February, we discussed the results of the ADRENAL trial and implications for clinical practice. Since that time, another large trial and meta-analysis has...
Several recent articles have challenged the long-held belief that we should treat fever in patients with sepsis? In this episode we review these recent...